cognitive

NSI-189

FDA: research-only

NSI-189 is a neurogenic compound that stimulates hippocampal neurogenesis and provides mood-lifting effects. It works on different aspects of neurogenesis and mood regulation than other cognitive peptides, making it especially effective in trauma-related depression. Boosts neurogenesis with a focus on hippocampal growth. Reduces neuroinflammation. Adds a mood-lifting neurogenic edge over time. Works on different aspects of neurogenesis and mood regulation than Dihexa or Cerebrolysin, especially effective in trauma-related depression. - Hippocampal neurogenesis stimulation - Mood resilience and anti-depression effects - Brain fog clearing - Cognitive enhancement - Trauma-related depression support - Neuroinflammation reduction - Standard: 20-40 mg oral daily -

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight
Half-life
CAS number
Route

28-day resets featuring NSI-189

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
  • Lipid Panel
DURING CYCLE
  • CMP
POST-CYCLE
  • CMP
  • CBC
Safety & Regulatory Status
FDA STATUS research-only

Regulatory status for NSI-189 may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.